Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It also delivers consumer and OTC THC-free CBD products that promote overall health and wellbeing, as well as testing and analytics capabilities to its customers. The company was incorporated in 2014 and is based in Beverly Hills, California.
Stock data | 2024 | Change |
---|---|---|
Price | $0.0002 | N/A |
Market Cap | $2.82K | N/A |
Shares Outstanding | 14.10M | N/A |
Employees | 25.00 | N/A |